跳到正文
Daisuke Kotani, MD, Ph.D 小谷 大輔· @DaisukeKotani · X·· 2 天前评分90

SANO

正文 · 原文

#ESMO26 | LBA78
Long-term results from SANO: Active surveillance vs standard surgery after nCRT in EC
▪️5y-OS: 50% vs 54%, HR 1.17 (95% CI 0.77-1.77)
▪️DFS: HR 1.39 (95%CI 0.94-2.06)
▪️5y-distant mets: 46% vs 29%, p<0.01
👉Despite no significant OS or DFS differences, the wide CIs and significantly higher distant mets rate highlight important challenges for implementing active surveillance in clinical practice. Looking forward to the presentation!
@myESMO @OncoAlert

1558 浏览 · 13 赞 · 9 转发 · 0 回复

会议摘要
LBA78按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上

Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: Long-term results of a cluster-randomised controlled trial (SANO)

https://esmocongress.esmo.org

来源:Daisuke Kotani, MD, Ph.D 小谷 大輔 · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org